Literature DB >> 17172372

Reinfection and relapse in early Lyme disease.

Peter J Krause1, Daniel T Foley, Georgine S Burke, Diane Christianson, Linda Closter, Andrew Spielman.   

Abstract

To determine whether recurrent episodes of appropriately treated Lyme disease are caused by reinfection or relapse, we monitored pertinent clinical manifestations and serology of residents of an endemic site each year for 14 years. Of 253 episodes of early Lyme disease recorded among 213 residents, we observed 40 recurrent episodes. Virtually all included an erythema migrans (EM) rash that appeared at body sites that differed from those of the initial rash, no subjects produced detectable levels of specific antibody between sequential episodes, all episodes occurred a year or more after the initial EM episode, and all occurred during late spring and early summer. People experiencing recurrent episodes tended to have frequent contact with vector ticks. Prompt administration of standard antibiotic therapy for early Lyme disease reliably eliminates persistent infection and prevents relapse.

Entities:  

Mesh:

Year:  2006        PMID: 17172372

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  18 in total

Review 1.  The anti-borreliae efficacy of phytochemicals and micronutrients: an update.

Authors:  Anna Goc; Matthias Rath
Journal:  Ther Adv Infect Dis       Date:  2016-07-04

2.  Differentiation of reinfection from relapse in recurrent Lyme disease.

Authors:  Robert B Nadelman; Klára Hanincová; Priyanka Mukherjee; Dionysios Liveris; John Nowakowski; Donna McKenna; Dustin Brisson; Denise Cooper; Susan Bittker; Gul Madison; Diane Holmgren; Ira Schwartz; Gary P Wormser
Journal:  N Engl J Med       Date:  2012-11-15       Impact factor: 91.245

3.  Serum reactivity against Borrelia burgdorferi OspA in patients with rheumatoid arthritis.

Authors:  Yu-Fan Hsieh; Han-Wen Liu; Tsai-Ching Hsu; James C-C Wei; Chien-Ming Shih; Peter J Krause; Gregory J Tsay
Journal:  Clin Vaccine Immunol       Date:  2007-09-19

4.  Critical Evaluation of the Linkage Between Tick-Based Risk Measures and the Occurrence of Lyme Disease Cases.

Authors:  Lars Eisen; Rebecca J Eisen
Journal:  J Med Entomol       Date:  2016-09-01       Impact factor: 2.278

Review 5.  Investigating disease severity in an animal model of concurrent babesiosis and Lyme disease.

Authors:  Purnima Bhanot; Nikhat Parveen
Journal:  Int J Parasitol       Date:  2018-10-24       Impact factor: 3.981

6.  Innate Immune Memory to Repeated Borrelia burgdorferi Exposure Correlates with Murine In Vivo Inflammatory Phenotypes.

Authors:  Quentin Bernard; Linden T Hu
Journal:  J Immunol       Date:  2020-11-09       Impact factor: 5.422

Review 7.  Laboratory Diagnosis of Lyme Borreliosis.

Authors:  John A Branda; Allen C Steere
Journal:  Clin Microbiol Rev       Date:  2021-01-27       Impact factor: 26.132

8.  Lyme Disease in Humans.

Authors:  Justin D Radolf; Klemen Strle; Jacob E Lemieux; Franc Strle
Journal:  Curr Issues Mol Biol       Date:  2020-12-11       Impact factor: 2.081

9.  Lyme disease: clinical diagnosis and treatment.

Authors:  T F Hatchette; I Davis; B L Johnston
Journal:  Can Commun Dis Rep       Date:  2014-05-29

10.  Variable VlsE is critical for host reinfection by the Lyme disease spirochete.

Authors:  Artem S Rogovskyy; Troy Bankhead
Journal:  PLoS One       Date:  2013-04-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.